NEW YORK, NY--(Marketwire - October 08, 2009) - OneMedPlace announced today that 25 healthcare and life science companies already have committed to present at its “OneMedForum 2010" finance conference, to be held January 12-14, 2010, in San Francisco at the Sir Francis Drake Hotel. The goal of the third annual OneMedForum event is to continue to be a vital resource for emerging healthcare/life science companies and healthcare/life science-focused investors. OneMedForum will include industry-focused panel sessions, numerous networking opportunities, and company presentations.
With more than three months until OneMedForum 2010, the following 25 companies already have committed to present: Access Pharmaceuticals (OB), ADVENTRX Pharmaceuticals (AMEX), BioDelivery Sciences International (Nasdaq), BioSante Pharmaceuticals (Nasdaq), Cardium Therapeutics (AMEX), Clarient (Nasdaq), Conceptus (Nasdaq), Cyclacel Pharmaceuticals (Nasdaq), Cytori Therapeutics (Nasdaq), CytRx (Nasdaq), Health-Link Europe (Private), Inovio Biomedical (AMEX), Invendo Medical (Private), Lucid (Private), Oxygen Biotherapeutics (OB), Nabi Biopharmaceuticals (Nasdaq), NovaBay Pharmaceuticals (AMEX), NuVue Therapeutics (Private), OPKO Health (AMEX), Peregrine Pharmaceuticals (Nasdaq), Pico-Tesla Magnetic Therapies (Private), Pressure BioSciences, (Nasdaq), NeoPharm (Nasdaq), Spherix (Nasdaq), and Xlumena (Private).
“We are extremely pleased with the early and overwhelming interest we are receiving from both the CEOs of emerging healthcare and life science companies as well as investors who are looking to identify ‘the next big thing’ in healthcare or the life sciences,” said Brett Johnson, President of OneMedPlace, organizer of the OneMedForum event. “We believe OneMedForum 2010 is shaping up to be one of the most significant meetings in the industry.”
To present at the OneMedForum event, contact Justin Schreiber at 212-734-1008 or send an email to Justin Schreiber at jschreiber@onemedplace.com.
About OneMedPlace
OneMedPlace is a virtual community of healthcare and life science companies. It has, for the first time, put in place the innovations that will shape the future of health and medicine--emerging companies and technologies seeking capital, distribution, visibility, and investors and strategic partners looking for health and medical innovations to invest in, acquire, license, distribute, purchase or utilize.
Contact:
Ronald Trahan, APR
Ronald Trahan Associates Inc.
508-359-4005, x108